Different mutations in SARS-CoV-2 associate with severe and mild outcome

Area of Science:

• Virology
• Genomics
• Clinical Medicine

Background:

• Genomic alterations in viruses can significantly impact disease outcomes.
• Identifying specific mutations in the SARS-CoV-2 genome is critical for understanding disease progression.

Purpose of the Study:

• To correlate protein-level mutations in the SARS-CoV-2 virus with clinical outcomes.
• To identify specific viral mutations associated with mild, severe, or critical disease.

Main Methods:

• Viral sequences from the GISAID repository were analyzed against a reference strain.
• Patient outcomes were categorized as mild, hospitalized, or severe (ICU admission or death).
• Statistical analyses, including Chi-square tests and False Discovery Rate (FDR), were used to assess mutation-outcome associations.

Main Results:

• 3,733 non-silent mutations were mapped to amino acid changes.
• Mutations linked to mild outcomes were found in ORF8, NSP6, ORF3a, NSP4, and the nucleocapsid (N) protein.
• Mutations associated with severe outcomes were identified in the surface glycoprotein (S), RNA-dependent RNA polymerase, ORF3a, NSP3, ORF6, and N proteins.
• A significant finding involved mutations within a phosphorylated region of the N protein, suggesting functional relevance.

Conclusions:

• Viral gene mutations demonstrate a direct correlation with clinical outcomes in SARS-CoV-2 infections.
• This research facilitates the rapid identification of SARS-CoV-2 variants associated with severe disease progression.